CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Infection Surveillance Solutions
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Infection Surveillance Solutions Market By Product and Services
1.2.2.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison By Product and Services (2015-2026)
1.2.2.2. Global Infection Surveillance Solutions Market Revenue Share By Product and Services in 2017
1.2.2.3. Software
1.2.2.4. Services
1.2.2.5. Others
1.2.3. Infection Surveillance Solutions Market By Infection Type
1.2.3.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison By Infection Type (2015-2026)
1.2.3.2. Surgical Site Infections (SSI)
1.2.3.3. Blood Stream Infections (BSI)
1.2.3.4. Urinary Tract Infections (UTI)
1.2.3.5. Others
1.2.4. Infection Surveillance Solutions Market By End Users
1.2.4.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Long Term Care Facilities
1.2.4.3. Hospitals
1.2.4.4. Others (Clinics, and Ambulatory Surgical Centers)
1.2.5. Infection Surveillance Solutions Market by Geography
1.2.5.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Hospitals Production Date of Global Infection Surveillance Solutions Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Infection Surveillance Solutions Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Infection Surveillance Solutions Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Infection Surveillance Solutions Major Manufacturers in 2017
CHAPTER 4. INFECTION SURVEILLANCE SOLUTIONS MARKET BY PRODUCT AND SERVICES
4.1. Global Infection Surveillance Solutions Revenue By Product and Services
4.2. Software
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Services
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. INFECTION SURVEILLANCE SOLUTIONS MARKET BY INFECTION TYPE
5.1. Global Infection Surveillance Solutions Revenue By Infection Type
5.2. Surgical Site Infections (SSI)
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Blood Stream Infections (BSI)
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Urinary Tract Infections (UTI)
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USERS
6.1. Global Infection Surveillance Solutions Revenue By End Users
6.2. Long Term Care Facilities
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others (Clinics, and Ambulatory Surgical Centers)
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY
7.1. North America Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Infection Surveillance Solutions Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY
8.1. Europe Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY
9.1. Asia-Pacific Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY
10.1. Latin America Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY
11.1. Middle East Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 12. AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY
12.1. Africa Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product and Services, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Infection Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Becton Dickinson and Company
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Premier Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Wolters Kluwer N.V
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Gojo Industries
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Baxter International Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. RL Solutions
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Truven Health Analytics
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Premier Inc
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope